2C-B-FLY Facts
Psychedelic;
Description
2C-B-FLY is a synthetic psychedelic of the phenethylamine class. It is a structurally locked structural analog of 2C-B — the ring system freezes the molecule into the active shape needed to engage serotonin receptors. That activation disrupts sensory filtering and produces the visual distortions and altered thinking characteristic of classical psychedelics.
Subjective effects include geometric visual patterns, color enhancement, mood elevation, and physical body load. The experience is more physically grounded and longer-lasting than 2C-B — a weighted, immersive quality from a persistent somatic heaviness beneath the visual and cognitive shifts.[1]
2C-B-FLY does not cause physical dependence,[2] and its toxic dose in humans is unknown. The primary danger is cardiovascular — it strongly constricts blood vessels and raises blood pressure[3] — amplified by its potential to inhibit enzymes that break down serotonin, making combinations with serotonergic drugs life-threatening.[4]
Dose and durationby route · individual sensitivity varies
Starts in 30 – 60 minLasts 7 – 12 hoursAfter-effects 6 – 24 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Moderate
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- LSD;
psilocybin; mescaline; DMT; 2C-B; DOB; DOI; DOC
Effectslikely at a common dose
- Perception
- Color enhancement;
Visual drifting; Color alteration; Music enhancement; Geometry; Visual breathing; +30 possible, including Spatial disorientation, Vestibular distortion, Visual haze / noise - Body
- Pupil dilation;
Wakefulness; Body high; Body scan awareness; Insomnia; Stimulation; +30 possible, including Heart rate perception changes, Muscle tension, Nausea - Thinking
- Pattern recognition enhancement;
Novelty enhancement; Aesthetic enhancement; Introspection enhancement; Openness enhancement; +33 possible, including Suggestibility enhancement, Memory suppression, Cognitive impairment - Feeling
- Emotional enhancement;
Euphoria; +8 possible, including Emotional lability, Anxiety, Dysphoria - Self
- none likely · 9 possible, including Derealization, Depersonalization
- Time
- Time alteration;
+3 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 5 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KPC, Ramaekers JG (2023) Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition — Clinical Pharmacology and Therapeutics doi:10.1002/cpt.2958
- [2]
- [3]^Rickli A, Kopf S, Hoener MC, Liechti ME (2015) Pharmacological profile of novel psychoactive benzofurans — British Journal of Pharmacology doi:10.1111/bph.13128
- [4]^Wagmann L, Brandt SD, Stratford A, Maurer HH, Meyer MR (2019) Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases — Drug Testing and Analysis doi:10.1002/dta.2494